Provided are approaches to establish a failsafe barrier to internal bleeding from percutaneous wounds to protect a patient from failed wound closure devices or related complications due to a variety of contributing factors such as state of systemic anticoagulation, errors in surgical procedure, vari
Provided are approaches to establish a failsafe barrier to internal bleeding from percutaneous wounds to protect a patient from failed wound closure devices or related complications due to a variety of contributing factors such as state of systemic anticoagulation, errors in surgical procedure, variability in patient anatomy, and the like. Systems include a clotting agent to encase, and thus isolate, substantially the entire wound access area from the rest of the patient and an instrument, such as an intravascular introducer sheath, inserted through a wound at an access site on a vessel, for delivering the clotting agent to the entire enveloping tissue region around the accessed area as a mold cavity to be filled with the clotting agent. With benefits of patient safety, user simplicity, and low healthcare cost driving the effort, autologous whole blood is the preferred injected agent.
대표청구항▼
1. A method for delivering a tissue forming fluid to internal bleeding pathways, the method comprising: delivering, by an apparatus, the tissue forming fluid through skin of a patient via an access path to a subcutaneous region surrounding a vessel in a body of the patient while the tissue forming f
1. A method for delivering a tissue forming fluid to internal bleeding pathways, the method comprising: delivering, by an apparatus, the tissue forming fluid through skin of a patient via an access path to a subcutaneous region surrounding a vessel in a body of the patient while the tissue forming fluid is in flowable form, wherein the tissue forming fluid comprises clotting material including autologous whole blood;filling the subcutaneous region with the tissue forming fluid;maintaining a position of at least a portion of the apparatus for a period of time to allow the tissue forming fluid to at least partially solidify into a tissue mass, wherein the tissue mass is capable of being reabsorbed by the body of the patient over time, andupon at least partial solidification, the tissue mass comprises a core pin channel impression in the form of the portion of the apparatus; andremoving the apparatus from the access path, wherein, upon removal, the core pin channel impression provides a channel for directing any bleeding out to the skin of the patient, thereby providing a failsafe mechanism to avoid internal bleeding. 2. The method of claim 1, wherein the apparatus comprises a cannula for providing fluid communication between a source of the tissue forming fluid and the subcutaneous region via the access path. 3. The method of claim 1, wherein the apparatus comprises a sheath. 4. The method of claim 3, wherein maintaining a position of the apparatus comprises maintaining the position of the sheath while utilizing the sheath for a subsequent intravascular medical procedure. 5. The method of claim 1, wherein the apparatus comprises a dilator for minimizing disruption of wounded tissue along the access path. 6. The method of claim 1, wherein the apparatus comprises a pressure gauge for identifying fullness of the subcutaneous region. 7. The method of claim 1, wherein the apparatus comprises a syringe containing the tissue forming fluid. 8. The method of claim 1, further comprising filling a portion of the access path with the tissue forming fluid, thereby enabling closure of the access path. 9. The method of claim 1, wherein: the vessel comprises a wound; andfilling the subcutaneous region with the tissue forming fluid comprises encasing the wound and the vessel. 10. The method of claim 1, wherein the subcutaneous region comprises internal bleeding pathways bounded by at least one of loose connective tissue, muscle, and cutaneous tissue. 11. The method of claim 1, wherein the core pin channel impression extends from an access opening in the vessel to the skin of the patient. 12. The method of claim 1, further comprising, after removing the apparatus, applying compression, thereby collapsing the core pin channel impression. 13. The method of claim 1, further comprising, after removing the apparatus, introducing another instrument into the core pin channel impression for performing an additional medical procedure. 14. A method for percutaneously closing a wound, the method comprising: establishing, using an apparatus, an access path to a percutaneous vessel through skin of a patient;placing a clotting agent in internal bleeding pathways surrounding the percutaneous vessel while in flowable form;maintaining a position of at least a portion of the apparatus for a period of time to allow the clotting agent to at least partially solidify into a tissue cast, wherein the tissue cast is formed within internal bleeding cavities surrounding the percutaneous vessel,the tissue cast is formed in part of autologous whole blood, andthe tissue cast, after solidification, is capable of being reabsorbed by the patient's body over time, andcomprises a core pin casting cavity in the form of the portion of the apparatus; andremoving the apparatus from the access path, wherein, upon removal, the core pin casting cavity provides a channel for directing any bleeding out to the skin of the patient, thereby providing a failsafe mechanism to avoid internal bleeding. 15. The method of claim 14, wherein the tissue cast is formed within a percutaneous region defined by one or more of interstitial loose connective tissue, blood vessels, cutaneous tissue, and muscle tissue. 16. The method of claim 14, wherein the core pin casting cavity provides access through the skin of a patient for a procedural instrument. 17. The method of claim 14, wherein the core pin casting cavity provides access for deploying a wound closure. 18. The method of claim 14, wherein the core pin casting cavity is collapsed for providing wound closure. 19. The method of claim 14, wherein the apparatus comprises an indicator for allowing controlled adjustment of the clotting agent.
Arias Juan J. (Hialeah FL) Bales Thomas O. (Miami FL) Gordon David P. (Stamford CT) Ryan Constance M. (Miami FL) Scarfone Frank A. (Boca Raton FL) Smith Kevin W. (Miami FL) Turkel David (Miami FL), Endoscopic hemostatic agent delivery system.
Edwardson Peter A. D.,GBX ; Fairbrother John E.,GBX ; Gardner Ronald S.,GBX ; Hollingsbee Derek A.,GBX ; Cederholm-Williams Stewart A.,GBX, Fibrin sealant compositions.
Edwardson Peter A. D.,GBX ; Fairbrother John E.,GBX ; Gardner Ronald S.,GBX ; Hollingsbee Derek A.,GBX ; Cederholm-Williams Stewart A.,GBX, Fibrin sealant compositions and methods for utilizing same.
Makower Joshua (Nanuet NY) Vidal Claude A. (Santa Barbara CA) LeMott Steven R. (East Lyme CT) Wells Rodney E. (East Lyme CT) Banks Thomas F. (Santa Barbara CA), Hemostatic implant introducer.
Makower Joshua (Nanuet NY) Vidal Claude A. (Santa Barbara CA) LeMott Steven R. (East Lyme CT) Wells Rodney E. (East Lyme CT) Banks Thomas F. (Santa Barbara CA), Hemostatic implant introducer.
Kensey Kenneth (Chester Springs PA) Nash John (Downingtown PA) Evans Douglas (King of Prussia PA), Hemostatic puncture closure system and method of use.
Kensey Kenneth (Chester Springs PA) Nash John (Dowington PA) Evans Douglas (Downington PA), Hemostatic puncture closure system including vessel location device and method of use.
Edwardson Peter A. D.,GBX ; Fairbrother John E.,GBX ; Gardner Ronald S.,GBX ; Hollingsbee Derek A.,GBX ; Cederholm-Williams Stewart A.,GBX, Kit for preparing a fibrin sealant.
Myers Gene (2727 S. Tamiami Trail ; Suite 2A Sarasota FL 34239) Coury William S. (2830 Bay Shore Cir. Sarasota FL 34234), Method and apparatus for arteriotomy closure.
Wijkamp Arnoldus Cornelius Johannes Maria,NLX ; Taeymans Yvo Madeleine Albert,BEX, Method and device for hemostatic treatment following catheterization.
Prud\homme Robert K. (Trenton NJ) Stanley ; Jr. Frederick W. (Midland MI) Langhorst Martin A. (Midland MI), Method for characterizing the molecular weight and molecular weight distribution of ultra-high molecular weight water so.
Matkovich Vlado I. (Glen Cove NY) Degen Peter J. (Huntington NY) Gsell Thomas C. (Glen Cove NY) Bormann Thomas (Seaford NY) Rothman Isaac (Brooklyn NY), Method for removing heparin from blood or plasma.
Edwardson Peter A. D.,GBX ; Fairbrother John E.,GBX ; Gardner Ronald S.,GBX ; Hollingsbee Derek A.,GBX ; Cederholm-Williams Stewart A.,GBX, Method of making a composition comprising a fibrin monomer.
Edwardson Peter A. D.,GBX ; Fairbrother John E.,GBX ; Gardner Ronald S.,GBX ; Hollingsbee Derek A.,GBX ; Cederholm-Williams Stewart A.,GBX, Methods and compositions using fibrin monomer to make a fibrin sealant.
Edwardson Peter A. D.,GBX ; Fairbrother John E.,GBX ; Gardner Ronald S.,GBX ; Hollingsbee Derek A.,GBX ; Cederholm-Williams Stewart A.,GBX, Nondynamic fibrin monomer on bandages, sutures, prostheses and dressings.
Muijs Van de Moer Wouter Matthijs,NLX ; Rienks Rienk,NLX, Occlusion assembly for sealing openings in blood vessels and a method for sealing openings in blood vessels.
Antanavich Richard D. (Paso Robles CA) Dorian Randel (Orinda CA), Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant.
Kensey Kenneth (Chester Springs PA) Nash John (Downingtown PA) Evans Douglas (King of Prussia PA), Plug device with pulley for sealing punctures in tissue and methods of use.
Winterton, Lynn Cook; Qiu, Yongxing; Lally, John Martin; Gabriel, Manal M., Polymeric articles having a lubricious coating and method for making the same.
Seidel Dietrich (Gttingen DEX) Feller Wolfgang (Melsungen DEX) Rosskopf Gerhard (Fuldabrck-Drnhagen DEX), Process and device for the specific adsorption of heparin.
Langer Robert S. (Cambridge MA) Linhardt Robert (Somerville MA) Cooney Charles L. (Brookline MA) Galliher Parrish M. (West Newton MA) Flanagan Margaret M. (Somerset MA) Klein Michael D. (Ann Arbor MI, Process for neutralizing heparin.
Edwardson Peter A. D.,GBX ; Fairbrother John E.,GBX ; Gardner Ronald S.,GBX ; Hollingsbee Derek A.,GBX ; Cederholm-Williams Stewart A.,GBX, Solid compositions of fibrin monomer.
Magro Alfred E. (Woburn MA) Rishton Michael (Reading MA), Tapered hemostatic device for use in conjunction with a catheter for alleviating blood leakage and method for using same.
Bass Lawrence S. (Little Neck NY) Libutti Steven K. (Lido Beach NY) Eaton Alexander M. (New York NY), Tissue bonding and sealing composition and method of using the same.
Weldon Thomas D. (Gainesville GA) Larsen Charles E. (Cumming GA) Rosen Jonathan J. (Alpharetta GA), Wound treating device and method for treating wounds.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.